Volker Huppert
Chief Development Officer, Glycostem Therapeutics
1990 - 1996 Studies of Bioprocess Engineering, RWTH Aachen, Germany
1996 - 2018 Miltenyi Biotec GmbH, Research & Development, Bergisch Gladbach, Germany
Clinical grade cell separation and cell culture, Hematopoietic Stem Cells, Natural Killer Cells,
"Graft Engineering" / Stem Cell Transplantation, "closed system", NK cell transduction,
Stem Cell Transduction, CliniMACS plus and Prodigy Cell Processing Systems
2018 ff. Glycostem Therapeutics B.V., Oss, The Netherlands
Cord Blood Hematopoietic Stem Cell derived Natural Killer Cells
GMP Setup and Introduction, Closed System, Process Development, Scaling